Vertex Pharmaceuticals Incorporated
SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS
Last updated:
Abstract:
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Status:
Application
Type:
Utility
Filling date:
9 Feb 2021
Issue date:
5 Aug 2021